Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
OUTLOOK THERAPEUTICS INC
41ONCurrent price
5.4 EUR
+0.2 EUR (+3.85%)
Last closed
5.76 USD
Company
www.outlooktherapeutics.com
ISIN
US69012T2069
Sector
Healthcare
Industry
Biotechnology
Exchange
Stuttgart Exchange
Capitalization
128 686 464 USD
Yield for 12 month
-29.22 %
1Y
3Y
5Y
10Y
15Y
41ON
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Address: Building F, Iselin, NJ, United States, 08852
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
37.2 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-44 188 USD
Last Year
-204 694 USD
Current Quarter
-28 672 USD
Last Quarter
-28 195 USD
Key Figures 41ON
1 year
3 years
5 years
10 years
EBITDA
-61 188 524 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-83.69 %
PEG Ratio
–
Return On Equity TTM
-3.65 %
Wall Street Target Price
37.2 USD
Revenue TTM
5 853 537 USD
Book Value
-3.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
658.3 %
Dividend Yield
–
Gross Profit TTM
-42 330 856 USD
Earnings per share
-5.89 USD
Diluted Eps TTM
-5.89 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 41ON
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 41ON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
14.03.2024
Dividend Date
18.03.2019
Stock Valuation 41ON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.8498
Enterprise Value Revenue
26.101
Price Sales TTM
13.2716
Enterprise Value EBITDA
-4.1278
Price Book MRQ
10.1912
Financials 41ON
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 41ON
For 52 weeks
4.61 USD
13.32 USD
50 Day MA
6.19 USD
Shares Short Prior Month
2 947 927
200 Day MA
7.56 USD
Short Ratio
10.99
Shares Short
2 989 293
Short Percent
18.6 %
BeatStart